Americans for Safe Access

SEPTEMBER 25, 2024

What's Inside For September 2024: DEA Hearing Delay on Cannabis Rescheduling Patients caught in the middle of CA Hemp Product Ban ASA releases What’s in Your Cannabis? A Patient & Consumer Guide to Navigating Cannabis Safety. Learn More about ASA Member Benefits & Join Today!

DEA 147

DEA Programs Patients Safety 147

NORML

JANUARY 13, 2020

Strait, Senior Policy Advisor, Diversion Control Division, Drug Enforcement Administration (DEA). The legislative hearing notice states that six bills will be discussed, including HR 3884 , the MORE Act, which recently was approved in the House Judiciary Committee by a bipartisan vote of 24-10 and waived by the House Small Business Committee.

Legislation 196

Legislation Marijuana Policy DEA 196

The Blunt Truth

JULY 18, 2022

Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.

DEA 98

DEA Data Decriminalization Legalization 98

Cannabis Law Report

FEBRUARY 28, 2020

After a significant outcry by the hemp community, the USDA is backing down from its requirement that all hemp be tested at DEA-registered labs for the 2020 season. However, hemp producers should be aware that the USDA expects to begin enforcing the requirement to use DEA-registered labs for the 2021 growing season.

DEA 59

DEA Hemp CBD Agriculture 59

Cannabis Law Report

DECEMBER 7, 2021

On November 16, 2021, the Drug Enforcement Agency (DEA) issued an advance notice of proposed rulemaking , exploring whether or not to create new federal regulations governing the practice of telepharmacy. The DEA’s notice provides the industry with an opportunity to provide insight and feedback that may help shape the new regulations.

DEA 52

DEA Patients Therapy Access 52

Cannabis Law Report

JUNE 28, 2021

Drug Enforcement Agency (“DEA”). While CBP has at least provided some response to the initial request, DEA has completely stonewalled the Initiative to date. While CBP has at least provided some response to the initial request, DEA has completely stonewalled the Initiative to date. Drug Enforcement Administration (DEA).

DEA 97

DEA Blood Pressure Safety Policy 97

Medical Marijuana Program Connection

MAY 2, 2024

The US Drug Enforcement Agency (DEA) is moving forward with plans to move marijuana from a Schedule I to a Schedule III controlled substance under the Controlled Substance Act (CSA), the US Department of Justice officials announced this week. First reported by the Associated Press and since confirmed by Medscape. Read More

DEA 53

DEA Marijuana Safety Patients 53

The Blunt Truth

AUGUST 27, 2020

The DEA has a new hemp rule. Recreational use would be legal for those 21 or older, with the sales tax revenue going to community colleges, public safety, health and roads. dea hemp rule. He did not address the DEA’s new rule and its effect on the industry’s survival. And traffic lights go green. and finally.

DEA 109

DEA Decriminalization Hemp Legalization 109

Veriheal

FEBRUARY 23, 2024

As the Drug Enforcement Administration (DEA) and federal government draw closer to moving cannabis from a Schedule I to a Schedule III substance , more groups have begun to put their weight behind the movement. While there is no date yet on when the formal decision from the DEA will be released, it could be as soon as a few weeks from now.

DEA 104

DEA Chronic Pain Treatment Therapy 104

Freedom Leaf

OCTOBER 15, 2018

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. schedules were created by the Controlled Substances Act (CSA) in 1970 and are interpreted and enforced by the DEA.

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

Cannabis Law Report

FEBRUARY 16, 2022

A 28-page DEA report — authored in August of 2021, and based on Department of Health and Human Services reviews of these psychedelics from 2012 — states, “These five tryptamines have no known medical use in the United States and are not marketed internationally as approved drug products. Read full report at.

DEA 52

DEA Safety Treatment Law 52

Cannabis Law Report

SEPTEMBER 9, 2019

The DEA’s announcement signals the “beginning of the end” of federal marijuana prohibition, as the policy change allows federal agencies to evaluate and assess the medical use and abuse potential of marijuana with (limited) political interference. BY EMILY BURNS, GREEN LIGHT LAW GROUP —.

DEA 45

DEA Law Policy Safety 45

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. ”We are pleased with the DEA ‘s cooperation and support to facilitate our company mission to service the unmet needs of patients suffering from these chronic diseases.”

DEA 51

DEA Clinical Trials THC Research and Development 51

FloridaMarijuana.net

JULY 8, 2018

According to the MAPS website they are “working to demonstrate the safety and efficacy of smoked botanical marijuana as a prescription medicine for specific medical uses to the satisfaction of the U.S. The study has received full approval from the FDA, DEA, and Institutional Review Boards (IRBs). Food and Drug Administration.

Strains 190

Strains Indica Hybrid Research and Development 190

Cannabis Law Report

AUGUST 27, 2021

ACS Laboratory Will Grant its Safety Seal to Any Product Testing Beyond the Minimum for a Full Panel of Tests. ACS Laboratory’s Tested Safe Certified Safety Seal is a physical symbol that products passed the strictest testing guidelines in the U.S. BOCA RATON, Fla. , Aug. BOCA RATON, Fla. , Aug.

Cannabinoids 98

Cannabinoids Programs Safety Hemp 98

Cannabis Law Report

JUNE 12, 2021

MONTEREY, CA – Biopharmaceutical Research Company (BRC), an active Drug Enforcement Administration (DEA) license holder, and CURE Pharmaceutical Holding Corp. BRC is a specialty pharmaceutical company that holds several DEA Registrations and is pioneering the federally legal cannabis space in the USA.

DEA 45

DEA Pharmaceutical Research and Development Compliance 45

Cannabis Law Report

JUNE 10, 2021

(OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has signed a partnership agreement with Biopharmaceutical Research Company , (BRC), an active Drug Enforcement Administration (DEA) license holder, to produce federally-compliant cannabis-based medical products.

Pharmaceutical 75

Pharmaceutical DEA Research and Development THC 75

The Cannigma

JULY 11, 2021

There’s zero research on the safety of products with high levels of delta-10-THC, so there’s no scientific evidence that these products are safe. Because delta-10 products are being made from hemp-derived CBD isolate, some proponents argue that it is legal under the 2018 Farm Bill, but the DEA doesn’t agree. . Is delta-10-THC legal?

THC 127

THC Cannabinoids Safety DEA 127

Canna Law Blog

MARCH 4, 2020

And as long as the healthcare provider in charge judges the infusion therapy to be ethical and not violative of safety standards, they may prescribe it accordingly. The FDA doesn’t have any regulations on point for the control and oversight of ketamine clinics when it comes to infusion therapy and the states don’t really either.

Therapy 107

Therapy Legalization Chronic Pain DEA 107

Medicinal Genomics

NOVEMBER 5, 2019

This change shouldn’t affect most hemp farmers who have no interest in cultivating psychoactive plants; however, it does remove a safety net. Another potential headache for farmers is that analytical laboratories must be registered with the DEA in order to perform compliance testing. What does this mean for hemp farmers?

THC 81

THC Hemp DEA Banking 81

Cannabis Law Report

JULY 13, 2021

The California legislation that would decriminalize some psychedelic substances under state law, Senate Bill 519, was approved in a 5-3 vote by the State Assembly’s Public Safety Committee in a June 29th hearing. This vote marks the bill’s first hearing in the Assembly after passing in a 21-16 vote by the State Senate on June 1.

Decriminalization 105

Decriminalization Legislation DEA Safety 105

Cannabis Law Report

JULY 20, 2022

Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.

DEA 52

DEA Data Decriminalization Legalization 52

Cannabis Law Report

JULY 18, 2022

Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.

DEA 52

DEA Data Decriminalization Legalization 52

Veriheal

APRIL 11, 2022

Drug Enforcement Agency (DEA). According to the company’s CEO, George Hodgin, “federally legal FDA- and DEA-approved cannabis-based drugs will absolutely upend the traditional pharmaceutical market.”. Groff confirmed that it had completed its first batch of medicinal-grade cannabis for research purposes on Feb. federal law.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

The Blunt Truth

MAY 15, 2020

The National Cannabis Industry Association would like to get the DEA out of research entirely, and state-level research could be a substitute for the federal program. The group promises to follow safety protocols, so they can muster the support they need, without risking anyone’s health. montana update. maine licensing.

Banking 106

Banking Research and Development Programs Advocacy 106

Veriheal

DECEMBER 19, 2023

The Drug Enforcement Administration (DEA) is working on amending the Farm Bill in 2024 to create new rules and regulations regarding synthetic weed. Since delta-8 is so unpopular in states with legal cannabis, the data suggests that it is often less appealing to consumers than actual weed.

Legalization 115

Legalization Edibles DEA Access 115

Illinois News Joint

NOVEMBER 6, 2024

percent have been interpreted by the Drug Enforcement Administration (DEA) as federally legal hemp. HB5309 will empower urban farmers, support small businesses, protect public safety, and position Illinois as a national leader.” Say that Delta-8 is safe despite never being used by humans until 2021 and no safety data exists on it.

Hemp 78

Hemp Agriculture THC DEA 78

TheAnswerPage

DECEMBER 23, 2021

In other words, the Drug Enforcement Agency (DEA) considers psilocybin to have a high potential for abuse, no currently accepted medical use, and a lack of accepted safety for use under medical supervision. Psilocybin is a Schedule I substance under the Controlled Substances Act. See the Answer.

DEA 45

DEA Safety 45

Veriheal

JUNE 30, 2023

The document also addresses study participant safety emphasizing how psychedelics’ psychoactive effects increase the potential for abuse. Lastly, the guide lays out the complex DEA registration process researchers much navigate to gain access to plants like psilocybin.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Cannabis Law Report

JUNE 15, 2021

Drug Enforcement Administration-McAlester Resident Office and DEA Denver. The investigation was initiated by the DEA Denver office’s “Front Range Task Force” after a Chinese money laundering organization was identified that sold black market marijuana “to fund and further their criminal activities,” the sheriff office stated.

DEA 51

DEA Concentrates Safety Marijuana 51

TheAnswerPage

DECEMBER 9, 2021

Has the Drug Enforcement Administration (DEA) issued any statements about the legal “loop hole” in the Farm Bill and the production and sale of ?8-THC? The DEA specifically lists ?8-THC 8-THC: legal status, widespread availability and safety concerns, Cannabis and Cannabinoid Research 6:5, 362–365, DOI: 10.1089/can.2021.0097.

DEA 40

DEA Agriculture Safety THC 40

The Cannigma

MAY 6, 2021

When it comes to safety, the two main factors to consider are production (standards and regulation) and research. Even if you were able to verify the production standards and active ingredients, there’s just not enough scientific literature to support the safety of consuming high levels of delta-8-THC in the long term.

THC 145

THC Cannabinoids Concentrates Hemp 145

Veriheal

AUGUST 19, 2020

The Drug Enforcement Administration (DEA) says that the word refers to opium and its derivatives. However, the DEA is an American agency, so it’s unlikely that the EU has consulted their definition. A definition for narcotic is a little complicated to pin down, though. Cannabis certainly wouldn’t fall under that umbrella.

Food 52

Food CBD DEA Safety 52

Cannabis Law Report

JUNE 16, 2021

Hemp-derived Delta-8 THC is having a big moment in 2021 in terms of popularity and, most recently, in terms of concerns over legality, safety, and accuracy. If you feel like you’ve been catching a lot of Delta-8 THC content in the media lately, those aren’t just your social media apps hacking your brain.

THC 90

THC Hemp Media Data 90

Cannabis Law Report

JUNE 20, 2019

Specifically, airmen are concerned about the safety of cannabidiol (CBD) oil use and how such use impacts an airman’s medical certificate. Be aware that federal law — not state law — governs FAA medical and pilot certification. The compound responsible for the euphoric, mind-altering effect is tetrahydrocannabinol (THC).

THC 74

THC CBD Oil DEA 74

Cannabis Law Report

AUGUST 23, 2021

Abernethy said, “We [FDA] remain focused on exploring potential pathways for CBD products to be lawfully marketed while also educating the public about these outstanding questions of CBD’s safety.”. She acknowledged that “FDA is considering the possibility of new legal pathways for CBD products.”.

Pets 105

Pets Hemp CBD Food 105

Cannabis Law Report

JULY 30, 2021

The FDA is currently in an ongoing process evaluating the science and safety of CBD and hemp derivatives in order to determine potential regulatory pathways for hemp. Regulatory Oversight of Hemp and Cannabis. The FDA already has primary regulatory authority over all hemp and hemp derivatives.

Hemp 105

Hemp Law Seed-To-Sale Food 105